Irfen Junior, Suspension

7680669330019 CH-66933 suspension
Irfen Junior, Suspension
Irfen Junior, Suspension
Irfen Junior, Suspension
1 / 3
google

Article details

Package size
200
Selling units
200
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/07/2025
Patient information leaflet
Français
11/07/2025
Patient information leaflet
Italien
11/07/2025
Summary of Product Characteristics
Allemand
11/07/2025
Summary of Product Characteristics
Français
11/07/2025
Summary of Product Characteristics
Italien
11/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance AIMDK
(N/A)
- Substance AIMDK
(N/A)
2.0 G Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
7.375 MG Substance HBESI

Reimbursement information

Public price
CHF 13.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2019

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66933
Drug name
Irfen Junior, Suspension
Galenic form
SUOR
ATC Code
M01AE01
Authorization status
Z
Dispensing category
B
First authorization
07/12/2018
Authorization expiration date
31/12/9999
IT Number
07.10.1.
Domain
Human medicine
Field of application
Antiphlogistikum, Analgetikum, Antipyretikum

Package details

Description (FR)
IRFEN Junior susp 100 mg/5ml fl 200 ml
Description (DE)
IRFEN Junior Susp 100 mg/5ml Fl 200 ml
Market launch
07/12/2018
Narcotic (BTM)
No

Original drug

Algifor Junior, Suspension
GTIN: 7680560460013
CHF 13.95
View original